Since the NPM-ALK/STAT3 signaling axis is the key oncogenic driving force in NPM-ALK + ALCL [11], we tested if the expression of FOXM1 carries any substantial impact on this signaling axis. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.